ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesotaother_biologicalPhase 2Active
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 89/ 100
Competitive context
26 Active assets in the Juvenile Myelomonocytic Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Masonic Cancer Center, University of Minnesota | Phase 4 | BBB |
Thiotepa St. Jude Children's Research Hospital | Phase 3 | BBB |
Busulphan Masonic Cancer Center, University of Minnesota | Phase 4 | BBB |
Fludarabine Children's Oncology Group | Phase 3 | BB |
FILGRASTIM Masonic Cancer Center, University of Minnesota | Phase 3 | BB |
View all 44 →
Same molecule, other indications
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →